| Trial ID: | L3112 |
| Source ID: | NCT00335465
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
Lantus Effect on Myocardial Glucose Metabolism in T2
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Insulin glargine
|
| Outcome Measures: |
Primary: effect of insulin treatment on myocardial function, perfusion and glucose metabolism., assessed before and after treatment|adverse events, throughout the study | Secondary: changes of myocardial structure and left ventricular systolic and diastolic function, at baseline and at the end of the study
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
15
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-09
|
| Completion Date: |
2008-06
|
| Results First Posted: |
|
| Last Update Posted: |
2009-12-07
|
| Locations: |
Sanofi-Aventis Administrative Office, Milan, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00335465
|
